BR3006-2
- Generic Name
- BR3006-2
A Study to Evaluate Drug-drug Interactions and Safety Between "BR3006-1", "BR3006-2", and "BR3006-3" in Healthy Volunteers
- First Posted Date
- 2023-07-19
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 37
- Registration Number
- NCT05951946
- Locations
- 🇰🇷
CHA Bundang Medical Center(CBMC), Seongnam-si, Gyeonggi-do, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath